Atlas Trials

Topical Rapamycin to Erase Angiofibromas in TSC

Clinical trial NCT01526356 · COMPLETED

Trial details

NCT number
NCT01526356
Sponsor
The University of Texas Health Science Center, Houston
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
AngiofibromasTuberous Sclerosis
Start date
2012-05-01
Primary completion
2014-08-01
Enrollment
179

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.